RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 136 filers reported holding RELAY THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.73 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,019,207 | -21.8% | 240,096 | +16.8% | 0.00% | 0.0% |
| Q2 2023 | $2,581,846 | -6.8% | 205,561 | +22.2% | 0.00% | -50.0% |
| Q1 2023 | $2,769,513 | +75.4% | 168,155 | +58.1% | 0.00% | +100.0% |
| Q4 2022 | $1,578,524 | -33.2% | 106,333 | +3.1% | 0.00% | -50.0% |
| Q3 2022 | $2,362,852 | +46.5% | 103,145 | +7.3% | 0.00% | +100.0% |
| Q2 2022 | $1,613,399 | -40.1% | 96,168 | +8.6% | 0.00% | -50.0% |
| Q1 2022 | $2,694,072 | +145.8% | 88,562 | +151.7% | 0.00% | +100.0% |
| Q4 2021 | $1,096,000 | +11.4% | 35,186 | +12.8% | 0.00% | 0.0% |
| Q3 2021 | $984,000 | -18.9% | 31,194 | -5.9% | 0.00% | 0.0% |
| Q2 2021 | $1,213,000 | +34.3% | 33,149 | +26.9% | 0.00% | 0.0% |
| Q1 2021 | $903,000 | +9.9% | 26,129 | +32.1% | 0.00% | 0.0% |
| Q4 2020 | $822,000 | +9.7% | 19,784 | +12.4% | 0.00% | 0.0% |
| Q3 2020 | $749,000 | – | 17,597 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 4,068,574 | $68,149,000 | 5.76% |
| SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $467,408,000 | 3.71% |
| BVF INC/IL | 4,384,805 | $73,445,000 | 3.55% |
| Boxer Capital, LLC | 2,669,132 | $44,708,000 | 2.83% |
| Nextech Invest Ltd. | 475,485 | $7,964,000 | 2.69% |
| EcoR1 Capital, LLC | 3,723,541 | $62,369,000 | 2.15% |
| HARBOURVEST PARTNERS LLC | 296,402 | $4,965,000 | 1.63% |
| Integral Health Asset Management, LLC | 436,262 | $7,307,000 | 1.50% |
| Alphabet Inc. | 1,568,753 | $26,277,000 | 1.43% |
| Fernwood Investment Management, LLC | 185,063 | $3,100,000 | 1.34% |